×

Optimal healthcare decisions: comparing medical treatments on a cost-effectiveness basis. (English) Zbl 1178.90190

Summary: This paper deals with medical treatments comparison from the cost-effectiveness viewpoint. A decision theory scheme is considered, where the decision space is the set of treatments involved, the space of states of nature consists of the respective net benefits of the treatments, and the utility function is one of two possible candidates. A first candidate is the one typically used in the literature on cost-effectiveness analysis, for which the utility of a decision is proportional to the net benefit gain, and a second one is of the type 0-1, which penalizes the wrong decisions with a fixed quantity. Their associated optimal decision rules, both frequentist and Bayesian, are analyzed and compared via frequentist evaluation of their performance, and the conclusion is that the latter beats the former in the sense of choosing the optimal treatment more often than any other, thus minimizing the proportion of wrong decisions. Illustrations with simulated and real data are provided.

MSC:

90B50 Management decision making, including multiple objectives
90B90 Case-oriented studies in operations research
62P30 Applications of statistics in engineering and industry; control charts
92C50 Medical applications (general)

Software:

BayesDA
PDFBibTeX XMLCite
Full Text: DOI

References:

[1] Al, M. J.; van Hout, B. A., A Bayesian approach to economic analysis of clinical trials: the case of stenting versus balloon angioplasty, Health Economics, 9; 599-609 (2000)
[2] Barton, G. R.; Briggs, A. H.; Fenwick, E. A., Optimal cost-effectiveness decisions: the role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfect information (EVPI), Value in Health, 11, 5, 886-897 (2008)
[3] Berger, J.; Bernardo, J. M., On the development of reference priors, (Bernardo, J. M.; Berger, J.; Dawid, A. P.; Smith, A. F.M., Bayesian Statistics, vol. 4 (1992), Oxford University Press: Oxford University Press Oxford), 35-60
[4] Brailsford, S.; Harper, P., OR in health, European Journal of Operational Research, 185, 3, 901-904 (2008)
[5] Chalabi, Z.; Epstein, D.; McKenna, C.; Claxton, K., Uncertainty and valued of information when allocating resources within and between healthcare programmes, European Journal of Operational Research, 191, 2, 530-539 (2008) · Zbl 1147.90011
[6] Claxton, K.; Lacey, L. F.; Walker, S. G., Selecting treatments: a decision theoretic approach, Journal of the Royal Statistical Society Series A, 163, 211-225 (2000)
[7] Dalal, S.; Hall, W. J., Approximating priors by mixtures of natural conjugate prior, Journal of the Royal Statistical Society Series B, 45, 278-286 (1983) · Zbl 0532.62017
[8] Diaconis, P.; Ylvisaker, D., Quantifying prior opinion, (Bernardo, J. M.; DeGroot, M.; Lindley, D.; Smith, A., Bayesian Statistics, vol. 2 (1985), North-Holland: North-Holland Amsterdam), 133-156 · Zbl 0673.62004
[9] Drummond, M. F.; Sculpher, M. J.; Torrance, G. W.; O’Brien, B. J.; Stoddart, G. L., Methods for the economic evaluation of health care programmes (2005), Oxford University Press: Oxford University Press Oxford
[10] Gelman, A.; Carlin, J. B.; Stern, H. S.; Rubin, D. B., Bayesian Data Analysis (2004), Chapman & Hall: Chapman & Hall Boca Raton · Zbl 1039.62018
[11] Heitjan, D. F.; Li, H., Bayesian estimation of cost-effectiveness: an importance-sampling approach, Health Economics, 13, 191-198 (2004)
[12] Hoch, J.; Rockx, M. A.; Krahn, A., Using the net benefit regression framework to construct cost-effectiveness acceptability curves: an example using data from a trial of external loop recorders versus Holter monitoring for ambulatory monitoring of “community acquired” syncope, BMC Health Services Research, 6, 68 (2006)
[13] Nixon, R.; Thompson, S., Parametric modelling of cost data in medical studies, Statistics in Medicine, 23, 1311-1331 (2004)
[14] O’Hagan, A.; Stevens, J. W., A framework for cost-effectiveness analysis from clinical trial data, Health Economics, 10, 302-315 (2001)
[15] O’Hagan, A.; Stevens, J. W., Bayesian methods for design and analysis of cost-effectiveness trials in the evaluation of health care technologies, Statistical Methods in Medical Research, 11, 469-490 (2002) · Zbl 1121.62647
[16] O’Hagan, A.; Stevens, J. W.; Montmartin, J., Bayesian cost-effectiveness analysis from clinical trial data, Statistics in Medicine, 20, 733-753 (2001)
[17] Pendharkar, P. C.; Rodger, J. A., The relationship between software development team size and software development cost, Communications of the ACM, 52, 1, 141-144 (2009)
[18] Pinto, J. L.; López, C.; Badı´a, X.; Coma, A., Análisis coste-efectividad del tratamiento antirretroviral de gran actividad en pacientes infectados por el VIH asintomáticos, Medicina Clı´nica, 114, 3, 62-67 (2000)
[19] Spieglehalter, D.; Feedman, L.; Parmar, M., Bayesian approaches to randomized trials (with discussion), Journal of the Royal Statistical Society Series A, 157, 357-416 (1994)
[20] Stinnett, A. A.; Mullahy, J., Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis, Medical Decision Making, 18, S68-S80 (1998)
[21] Thompson, S.; Nixon, R., How sensitive are cost-effectiveness analyses to choice of parametric distributions?, Medical Decision Making, 25, 416-423 (2005)
[22] Vanness, D. J.; Mullahy, J., Perspectives on mean-based evaluation of health care, (Jones, A. M., Elgar Companion to Health Economics (2006), Edward Elgar Publishing: Edward Elgar Publishing Cheltenham), 526-536
[23] Vázquez-Polo, F. J.; Negrı´n, M. A.; Badı´a, X.; Roset, M., Bayesian regression models for cost-effectiveness analysis, European Journal of Health Economics, 50, 45-52 (2005)
[24] Weinstein, M. C.; Manning, W. G., Theoretical issues in cost-effectiveness analysis, Journal of Health Economics, 16, 121-128 (1997)
[25] Willan, A.; Briggs, A. H., Statistical Analysis of Cost-effectiveness Data (2006), Wiley: Wiley Chichester · Zbl 1129.62109
[26] Willan, A.; Kowgier, M., Cost-effectiveness analysis of a multinational RCT with a binary measure of effectiveness and an interacting covariate, Health Economics, 17, 777-791 (2008)
[27] Willan, A.; Lin, D. Y., Incremental net benefit in randomized clinical trials, Statistics in Medicine, 20, 1563-1574 (2001)
This reference list is based on information provided by the publisher or from digital mathematics libraries. Its items are heuristically matched to zbMATH identifiers and may contain data conversion errors. In some cases that data have been complemented/enhanced by data from zbMATH Open. This attempts to reflect the references listed in the original paper as accurately as possible without claiming completeness or a perfect matching.